Table 1:

Clinical, imaging, and pathologic patient population characteristics^a

Patient No.	ADC Group	Age (yr)/Sex	No. Enhancing Lesions	Response to Tx	ADC_25%	ADC_min	ADC_mean	Overall Cellularity
1	Low	45/F	MP	PD	534	156	637	High
2	Low	82/F	SG	PD	541	167	745	High
3	Low	57/M	MP	PD	646	191	894	High
4	Low	61/M	MP	PR	528	214	877	High
5	Low	62/F	MP	PD	589	280	681	High
6	Low	54/M	MP	PD	638	338	749	Low
7	Low	70/M	SG	PR	623	367	719	High
8	Low	54/F	SG	CR	688	456	805	High
9	Low	26/M	SG	CR	692	398	835	High
10	High	52/F	MP	CR	693	294	779	Low
11	High	43/F	SG	CR	725	371	876	High
12	High	81/M	MP	CR	822	411	959	Low
13	High	53/F	MP	CR	831	414	873	Mixed
14	High	68/M	MP	CR	842	479	1016	Low
15	High	61/F	MP	CR	772	510	781	Low
16	High	53/M	MP	CR	741	525	891	Low
17	High	56/F	MP	CR	815	609	893	Mixed
18	High	67 mol/L	SG	CR	906	614	933	Low

Note:—ADC indicates apparent diffusion coefficient; MP, multiple; SG, single; Tx, treatment; PD, progressive disease; PR, partial response; CR, complete response; ADC_25%, 25th percentile ADC value; ADC_min, minimum ADC value; ADC_mean, mean ADC value.
^a Patients are stratified on the basis of the median 25th percentile value.